Orexigen Therapeutics, Inc. (NASDAQ:OREX) Posts Basic Consolidated EPS Of $-5.2381

0

Orexigen Therapeutics, Inc. (NASDAQ:OREX)managed to report annual basic consolidated EPS of $-5.2381, which was for the year ended2015-12-31.The company reported basic consolidated EPS of $-5.2381 for the quarter ended 2015-12-31.

EPS from continuing operations

If you look at the performance of the company’s continuing operations, you see that EPS generated from such operations was {EPS_BASIC_CONT_OPER:1541}} for the year ended 2015-12-31. As for the quarter ended 2015-12-31, continuing operations produced EPS of $-1.7321.

EPS contribution from parent

Orexigen Therapeutics, Inc. (NASDAQ:OREX) received of $-5.2381 EPS boost from the parent company for the annual period ended

For the year ended 2015-12-31, the parent of Orexigen Therapeutics, Inc. (NASDAQ:OREX) contributed EPS of $-5.2381 to the company’s bottom-line. But for the quarter ended 2015-12-31, EPS boost from the parent was cited as $-5.2381.

What About Basic net EPS

The basic net EPS that Orexigen Therapeutics, Inc. (NASDAQ:OREX) reported for the year ended 2015-12-31 stood at $-5.2. For the quarter ended 2015-12-31, the company posted basic net EPS of $-5.2.

What About Consolidated Diluted EPS?

Orexigen Therapeutics, Inc. (NASDAQ:OREX)’s consolidated diluted EPS for the year ended 2015-12-31 was reported as $-5.2381. For the quarter ended 2015-12-31 the metric was$-5.2381.

Basic diluted EPS

The company managed to register diluted EPS from continuing operation of at $-5.2381 for the yearended 2015-12-31. But diluted EPS from continuing operations for the quarter ended 2015-12-31 came in at $-5.2381.

Net diluted EPS

Net diluted EPS posted by Orexigen Therapeutics, Inc. (NASDAQ:OREX) for the year ended 2015-12-31 was $-5.2. On quarterly basis, net diluted EPS for the quarter ended 2015-12-31 was reported as $-5.2.

What portion of diluted EPS came from parent?

For the annual period ended 2015-12-31, the parent company of Orexigen Therapeutics, Inc. (NASDAQ:OREX) said that it parent company boosted its diluted EPS by$-5.2381 in the year ended 2015-12-31. For the quarter ended 2015-12-31, the parent company’s contribution to diluted EPS was $-5.2381.

The company reported net basic EPS of $-5.2 for the year ended 2015-12-31 and net basic EPS of $-5.2 for the quarter ended 2015-12-31.

The number of Orexigen Therapeutics, Inc. (NASDAQ:OREX)’s basic shares outstanding at the end of the annual period ended 2015-12-31 was 13.113. That compares with 13.113 basic shares outstanding for the quarter ended 2015-12-31.

Orexigen Therapeutics, Inc. (NASDAQ:OREX) had 13.113 diluted shares outstanding at the end of the annual period ended 2015-12-31. But for the quarter ended 2015-12-31, diluted outstanding shares were 13.113.

1 Chart Pattern Every Investor Should Know

This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...

Click Here to See This Now.

(Visited 68 times, 1 visits today)